
|Articles|February 15, 2004
Corneal collagen cross-linking halts keratoconus progression
Anaheim, CA-Cross-linking of corneal collagen by topical treatment with riboflavin and ultraviolet (UV) light exposure shows promise as a safe, effective, simple, and inexpensive nonsurgical treatment for keratoconus, said Theo Seiler, MD, PhD, at the annual meeting of the American Academy of Ophthalmology.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Ophthalmology pipeline watch: Key trial results and PDUFA dates for Q1 2026
2
PRIMA retinal implant restores vision in patients with advanced GA
3
Ocugen releases positive preliminary 12-month data from phase 2 ArMaDa trial
4
Ocugen publishes phase 1 GARDian1 gene therapy data for Stargardt disease
5














































